Clock-Based Method May Miss Nocturnal Hypoglycemia in Diabetes Patients: Study Calls for Sleep Trackers
UK: In a recent analysis, the Hypo-METRICS study has shed light on the prevalence of nocturnal hypoglycemia and sleep-related hypoglycemia among individuals with diabetes. The researchers compared the rates of clock-based nocturnal hypoglycemia and hypoglycemia while asleep among patients with diabetes.
The study, published in Diabetes Technology & Therapeutics, revealed that the traditional clock-based approach for assessing nocturnal hypoglycemia may underestimate hypoglycemia while asleep in patients with type 1 and type 2 diabetes.
Nocturnal hypoglycemia refers to low blood sugar levels that occur during sleep. In contrast, sleep-related hypoglycemia encompasses low blood sugar incidents that may affect an individual's sleep patterns or overall well-being. Nocturnal hypoglycemia is typically measured between 00:00 and 06:00. However, these time frames may not align with actual sleeping patterns, raising questions about whether this approach introduces bias.
Against the above background, Gilberte Martine-Edith, King's College London, London, United Kingdom, and colleagues aimed to compare the rates of hypoglycemia occurring during sleep with those of clock-based nocturnal hypoglycemia in adults with type 1 diabetes (T1D) or insulin-treated type 2 diabetes (T2D). Specifically, they examined how often hypoglycemic episodes happen during sleep versus at specific nighttimes based on a clock schedule in these populations.
Participants in the Hypo-METRICS study used a blinded continuous glucose monitor and a Fitbit Charge 4 activity monitor for 10 weeks. They tracked hypoglycemic events through a smartphone app. Hypoglycemia detected by the sensor (SDH) and reported by participants (PRH) were classified into nocturnal (00:00–06:00) versus diurnal and into occurrences during sleep versus wakefulness, as indicated by the Fitbit sleep data. Paired-sample Wilcoxon tests were employed to analyze differences in hypoglycemia rates across these categories.
The study led to the following findings:
- 574 participants [47% T1D, 45% women, 89% white, median age 56 years, and hemoglobin A1c 7.3%] were included.
- Median sleep duration was 6.1 h, bedtime and waking time ∼23:30 and 07:30, respectively.
- There were higher median weekly rates of SDH and PRH while asleep than clock-based nocturnal SDH and PRH among people with T1D, especially for SDH <70 mg/dL (1.7 versus 1.4).
- Higher weekly rates of SDH while asleep than nocturnal SDH were found among people with T2D, especially for SDH <70 mg/dL (0.8 versus 0.7).
"Using the 00:00 to 06:00 time window as a proxy for sleep may lead to an underestimation of hypoglycemia occurring during actual sleep periods," the researchers wrote.
"Future research on hypoglycemia should incorporate sleep trackers to more accurately capture and reflect episodes of hypoglycemia during true sleep intervals," they concluded.
Reference:
Martine-Edith G, Divilly P, Zaremba N, Søholm U, Broadley M, Baumann PM, Mahmoudi Z, Gomes M, Ali N, Abbink EJ, de Galan B, Brøsen J, Pedersen-Bjergaard U, Vaag AA, McCrimmon RJ, Renard E, Heller S, Evans M, Cigler M, Mader JK, Speight J, Pouwer F, Amiel SA, Choudhary P, Hypo-Resolve FT. A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes: Findings from the Hypo-METRICS Study. Diabetes Technol Ther. 2024 Jul;26(7):433-441. doi: 10.1089/dia.2023.0522. Epub 2024 Apr 17. PMID: 38386436.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd